The Future of ECG Monitoring: Wearables and Remote Device

The Future of ECG Monitoring: Wearables and Remote Device
A physician analyzing the ECG results of a patient recorded using a wearable ECG machine
A physician analyzing the ECG results of a patient recorded using a wearable ECG machine

What is ECG?

What are the Risk Factors for Heart Disease?

Symptoms Associated with Heart Diseases

An electrocardiogram being printed after testing

Invention of Wearable ECG Monitoring Devices

How Does a Remote ECG Monitoring Device Work?

Properties of a Wearable ECG Machine

An ECG is in progress while the patient is asked to do exercise
An ECG is in progress while the patient is asked to do exercise

Advantages of a Continuous ECG Monitoring Device

Wearable ECG Machines: Examples

● ECG Holter Monitor System

● Wrist Wearables-PPG Sensor Incorporated Smart Watches

·  ECG Patches-ZioPatch by iRhythm Technologies

ECG from a conventional ECG machine
ECG from a conventional ECG machine

Conclusion

References

  1. https://www.cdc.gov/heartdisease/facts.htm
  2. https://professional.heart.org/-/media/PHD-Files-2/Science-News/2/2023-Heart-and-Stroke-Stat-Update/2023-Statistics-At-A-Glance-final_1_17_23.pdf
  3. 10.11909/j.issn.1671-5411.2016.06.015
  4. https://www.frontiersin.org/articles/10.3389/fcvm.2022.853614/full
uzma e1714761913269

PhD Scholar (Pharmaceutics), MPhil (Pharmaceutics), Pharm D, B. Sc.

Uzma Zafar is a dedicated and highly motivated pharmaceutical professional currently pursuing her PhD in Pharmaceutics at the Punjab University College of Pharmacy, University of the Punjab. With a comprehensive academic and research background, Uzma has consistently excelled in her studies, securing first division throughout her educational journey.

Uzma’s passion for the pharmaceutical field is evident from her active engagement during her Doctor of Pharmacy (Pharm.D) program, where she not only mastered industrial techniques and clinical case studies but also delved into marketing strategies and management skills.

Throughout her career, Uzma has actively contributed to the pharmaceutical sciences, with specific research on suspension formulation and Hepatitis C risk factors and side effects. Additionally, Uzma has lent her expertise to review and fact-check articles for the Health Supply 770 blog, ensuring the accuracy and reliability of the information presented.

As she continues her PhD, expected to complete in 2025, Uzma is eager to contribute further to the field by combining her deep knowledge of pharmaceutics with real-world applications to meet global professional standards and challenges.